Status:
NOT_YET_RECRUITING
Unravelling the Measles Paradox in Children
Lead Sponsor:
Erasmus Medical Center
Conditions:
MEASLES DISEASE
Eligibility:
All Genders
4-17 years
Brief Summary
Measles is caused by measles virus (MeV). The disease is associated with lymphopenia and immune suppression, which is an important cause of measles-associated morbidity and mortality. Measles-induced ...
Detailed Description
Measles is caused by measles virus (MeV). The disease is associated with lymphopenia and immune suppression, which is an important cause of measles-associated morbidity and mortality. Measles-induced ...
Eligibility Criteria
Inclusion
- Group A
- Aged 4 - 17 years old
- Susceptible to measles
- No pre-existing immunity against measles (vaccination or earlier infection)
- Group B
- Aged 4 - 17 years old
- Protected against measles due to vaccination or earlier infection
Exclusion
- A potential subject who meets any of the following criteria will be excluded from participation in this study:
- Diagnosed chronic disease that lasted over 3 months
- Immune suppression (due to medication or underlying disease)
- Group A; Detectable MeV-antibodies in the T1 blood sample
Key Trial Info
Start Date :
January 3 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2029
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06923631
Start Date
January 3 2026
End Date
April 1 2029
Last Update
November 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ErasmusMC
Rotterdam, South Holland, Netherlands, 3015GD